ArcARoma AB: 210318 ArcAroma achieves technological breakthrough in world market for health drinks - cold-pressed green tea
Press release 2021-03-18
ArcAroma's juiceCEPT® application, which was developed for the treatment of fruit and vegetable juices, has now been evaluated as an improving part of the production of cold-pressed green tea. Tests in ArcAroma's own lab show that the cold brewing time can be reduced from 24 hours to 30 minutes by using CEPT® - with retained antioxidant qualities.
- We are proud that we can demonstrate so many positive effects by using our treatment on cold-pressed green tea – it is a success for juiceCEPT®. Our evaluation shows that we can significantly reduce the cold brewing time, while maintaining the natural taste and all the positive qualities from the antioxidants. The market for cold-pressed green tea has great potential and our new application area has already been received with great interest, not least in China, says Johan Möllerström, CEO of ArcAroma.
Tea is the drink most consumed in the world after water - over two billion cups of tea are consumed every day. The global tea market had sales of more than USD 52 billion in 2018 and is expected to exceed USD 81 billion by 2026. In China, which is the world's largest market for green tea, approximately 300,000 tonnes of green tea are consumed per year.
ArcAroma's CEPT® technology has been shown to have several positive effects on the cold brewing process for green tea. Green tea differs from other types of tea in that it is not fermented or heated, which means that the tea leaves' vitamins, antioxidants and positive qualities are preserved. ArcAroma's evaluation is summarized as follows:
• Extraction of polyphenols > 500 mg / liter
• Enhanced extraction of Vitamin C
• Less bitter tannins are extracted
• The tea's natural taste, aromas and sweetness are maintained
• Cold brewing time is reduced from 24 hours to 30 minutes
• The treatment adds a minimal temperature increase of no more than 6° Celsius
For more information, please contact:
Johan Möllerström, CEO
(+46) 768 – 86 81 78
About ArcAroma AB (publ)
ArcAroma has developed a patented technology that controls and applies electrical pulses to optimize various biological processes. The CEPT® platform, which is a high-voltage generator combined with a treatment chamber, uses the technology within FoodTech for increased extraction from the raw material and extended shelf-life and increased quality of the final product. Within CleanTech, the CEPT® platform is used for sewage sludge treatment and biogas production. The platform uses short-term high-voltage pulses (PEF) that crush the cell membrane and eliminate unwanted microorganisms.
Our vision is to contribute to a sustainable world by offering efficient green cutting-edge technology that is easy to use in the areas of FoodTech and CleanTech.
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Boyden15.4.2021 03:24:01 CEST | Press release
Record year for Boyden Denmark in 2020
Boyden15.4.2021 03:23:51 CEST | Pressemeddelelse
Rekordår for det nye Boyden-team i Danmark
TigerGraph, Inc.8.4.2021 15:01:29 CEST | Press release
TigerGraph’s Graph + AI Summit 2021 to Feature 40+ Sessions, Live Workshops and Speakers from JPMorgan Chase, NewDay, Pinterest, Jaguar Land Rover and More
Agillic A/S7.4.2021 09:01:28 CEST | Press release
Agillic launches a new fast and advanced SMS editor to help clients deliver personalised SMS experiences
TigerGraph, Inc.30.3.2021 15:29:56 CEST | Press release
Technical University of Denmark uses TigerGraph to help find more effective treatments for acute lymphoblastic leukemia
Møns Bank A/S26.3.2021 07:03:33 CET | Pressemeddelelse
Indkaldelse til ekstraordinær generalforsamling 19. april 2021
Sika AG26.3.2021 07:02:09 CET | Press release
SIKA ACQUIRES FLOORING ADHESIVES BUSINESS IN THE USA
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom